Efficacy and tolerability of multidrug therapy for hypertriglyceridemia

Journal of Clinical Lipidology

Volumn 3, Issue 5, 2009, Pages 341-344

  Polsani, Venkateshwar R ^a   Nambi, Vijay ^a   Virani, Salim S ^a   Zoch, Danièle ^a   Yang, Eric Y ^a   Jones, Peter H ^a   Ballantyne, Christie M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Combination therapy; Dyslipidemia; Hypertriglyceridemia; Triglycerides

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; EZETIMIBE; FENOFIBRATE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIVER DYSFUNCTION; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHABDOMYOLYSIS; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

EID: 70349846380     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2009.09.003     Document Type: Article

References (10)

1. Miller M., Cannon C.P., Murphy S.A., Qin J., Ray K.K., and Braunwald E. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 51 (2008) 724-730
2. Ford E.S., Li C., Zhao G., Pearson W.S., and Mokdad A.H. Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch Intern Med 169 (2009) 572-578
3. Athyros V.G., Papageorgiou A.A., Hatzikonstandinou H.A., et al. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia. Am J Cardiol 80 (1997) 608-613
4. Gagne C., Gaudet D., and Bruckert E. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Circulation 105 (2002) 2469-2475
5. Pauciullo P., Borgnino C., Paoletti R., Mariani M., and Mancini M. Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT study). Atherosclerosis 150 (2000) 429-436
6. Farnier M., Roth E., Gil-Extremera B., et al. Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia. Am Heart J 153 (2007) 335 e331-e338
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
8. FIELD Study Investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study). Lancet 366 (2005) 1849-1861
9. Ballantyne C.M., Davidson M.H., McKenney J., Keller L.H., Bajorunas D.R., and Karas R.H. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study). Am J Cardiol 101 (2008) 1428-1436
10. Davidson M.H., Stein E.A., Bays H.E., et al. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther 29 (2007) 1354-1367